These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30426333)

  • 21. The role of nebivolol in the management of hypertensive patients: from pharmacological profile to treatment guidelines.
    Ferri C
    Future Cardiol; 2021 Nov; 17(8):1421-1433. PubMed ID: 34060323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A; Nuzum DS; Jolly JL
    Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation.
    Weiss R
    Vasc Health Risk Manag; 2006; 2(3):303-8. PubMed ID: 17326335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension.
    Li B; Zhang Q; Zhang H; Wang C; Xiu R
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32342981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment.
    Ayyagari R; Xie J; Cheng D; Wu EQ; Huang XY; Chen S
    J Clin Hypertens (Greenwich); 2018 Jun; 20(6):1058-1066. PubMed ID: 29902367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: A prospective, randomized, double-blind pilot study.
    Kook H; Hong SJ; Yang KS; Lee S; Kim JS; Park CG
    PLoS One; 2020; 15(9):e0239039. PubMed ID: 32915892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.
    Koumaras C; Tziomalos K; Stavrinou E; Katsiki N; Athyros VG; Mikhailidis DP; Karagiannis A
    J Am Soc Hypertens; 2014 Feb; 8(2):74-82. PubMed ID: 24139833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.
    Sander GE; Giles TD
    Expert Opin Pharmacother; 2015 Apr; 16(5):763-70. PubMed ID: 25747524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nebivolol: a review of its clinical and pharmacological characteristics.
    Gielen W; Cleophas TJ; Agrawal R
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):344-57. PubMed ID: 16961165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockade in hypertension and congestive heart failure.
    Ambrosioni E; Bacchelli S; Esposti DD; Borghi C
    J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S25-31. PubMed ID: 11811389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysis.
    Farmakis IT; Pyrgidis N; Doundoulakis I; Mykoniatis I; Akrivos E; Giannakoulas G
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):903-914. PubMed ID: 33945044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
    Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M
    Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N; Lim PO; MacDonald TM
    Circulation; 2001 Jul; 104(5):511-4. PubMed ID: 11479245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension.
    Mende CW; Giles TD; Bharucha DB; Ferguson WG; Mallick M; Patel MD
    J Clin Hypertens (Greenwich); 2017 Jun; 19(6):632-639. PubMed ID: 28075064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
    Cazzola M; Matera MG; Ruggeri P; Sanduzzi A; Spicuzza L; Vatrella A; Girbino G
    Respiration; 2004; 71(2):159-64. PubMed ID: 15031571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of nebivolol in hypertensive patients: a meta-analysis of randomized controlled trials.
    Liu JY; Guo LN; Peng WZ; Jiang Y; Wang AL; Guo XM; Xu ZS
    J Int Med Res; 2020 Oct; 48(10):300060520931625. PubMed ID: 33081551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebivolol in the treatment of arterial hypertension.
    Olawi N; Krüger M; Grimm D; Infanger M; Wehland M
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):189-201. PubMed ID: 31066991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebivolol: new therapy update.
    Sule SS; Frishman W
    Cardiol Rev; 2006; 14(5):259-64. PubMed ID: 16924166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.